Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.58 is 22% below its 5-year average of 7.20, near the low end of its 5-year range (0.36–18.37).
As of the fiscal period ended Tuesday, June 30, 2026. 37.67% above its 12-month average of 4.05.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.58.
CURRENT RATIO
5.58
CURRENT RATIO AVG TTM
4.05
CURRENT RATIO AVG 3Y
4.77
CURRENT RATIO AVG 5Y
7.20
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+37.67%
CURRENT VS 3Y AVG
+16.96%
CURRENT VS 5Y AVG
-22.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+48.71%
vs the sector median at left
Market Cap
$4.55M
Current Ratio
2.81
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
Market Cap
$4.47M
Current Ratio
40.30
TTM Avg
26.48
3Y Avg
43.98
5Y Avg
50.08
Market Cap
$4.30M
Current Ratio
1.57
TTM Avg
3.49
3Y Avg
6.45
5Y Avg
7.07
Market Cap
$4.72M
Current Ratio
8.63
TTM Avg
2.65
3Y Avg
2.36
5Y Avg
5.21
Market Cap
$4.94M
Current Ratio
7.43
TTM Avg
7.85
3Y Avg
10.06
5Y Avg
11.10
Market Cap
$4.95M
Current Ratio
10.60
TTM Avg
4.75
3Y Avg
13.42
5Y Avg
23.90
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CalciMedica, Inc. (CALC) | $4.74M | 5.58 | 4.05 | 4.77 | 7.20 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 2.81 | 3.29 | 4.75 | 4.47 |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.47M | 40.30 | 26.48 | 43.98 | 50.08 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.30M | 1.57 | 3.49 | 6.45 | 7.07 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.72M | 8.63 | 2.65 | 2.36 | 5.21 |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.94M | 7.43 | 7.85 | 10.06 | 11.10 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.95M | 10.60 | 4.75 | 13.42 | 23.90 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.23M | 1.99 | 1.05 | 3.08 | 3.15 |
| Imunon, Inc. (IMNN)vs › | $5.06M | 1.82 | 1.99 | 2.53 | 3.43 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.01M | 1.12 | 0.07 | 0.07 | 0.12 |
Current Ratio
5.58
Quick Ratio
5.58
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.58 |
| 2026-03-31 | 1.61 |
| 2025-12-31 | 3.58 |
| 2025-09-30 | 4.04 |
| 2025-06-30 | 5.45 |
| 2025-03-31 | 5.66 |
| 2024-12-31 | 5.34 |
| 2024-09-30 | 4.15 |
| 2024-06-30 | 5.22 |
| 2024-03-31 | 6.21 |
| 2023-12-31 | 2.88 |
| 2023-09-30 | 4.14 |
| 2023-06-30 | 4.98 |
| 2023-03-31 | 2.73 |
| 2022-12-31 | 0.36 |
| 2022-09-30 | 11.98 |
| 2022-06-30 | 11.95 |
| 2022-03-31 | 13.77 |
| 2021-12-31 | 16.53 |
| 2021-09-30 | 16.59 |
| 2021-06-30 | 18.37 |
| 2021-03-31 | 14.15 |
| 2020-12-31 | 14.18 |
| 2020-09-30 | 12.29 |
| 2020-06-30 | 2.45 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.96 |
| 2019-09-30 | 0.00 |
